TILs have become a focal point in cancer immunotherapy, a treatment approach that harnesses the body's immune system to fight cancer. By isolating and expanding these cells outside the patient's body and then reinfusing them, researchers aim to enhance the immune system's ability to target and destroy cancer cells. This approach has shown promise in treating certain types of cancers, such as melanoma.
